EBM (8409.TWO) monthly revenue, September 2026
EBM reported revenue of NT$0.03bn for September 2026, up 50.0% from the previous month and down 60.3% from a year earlier. Year-to-date revenue was NT$0.15bn, down 9.1% year on year. It ranked 147 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.03 | 50.0 | -60.3 |